Bifidobacterium

Probiotics/Drug Interactions:

  • Anti-inflammatory agentsAnti-inflammatory agents: Increases in serum IL-1-beta have been observed following LGG supplementation; however, no differences were seen in IL-6, TNF-alpha, MPO, IL-10, or IL-12 (33).
  • ImmunostimulantsImmunostimulants: In human studies, supplementation with probiotics has been shown to enhance various immune system parameters in healthy subjects (29; 44; 18; 19; 49), in HIV-positive subjects (47), and during vaccination (38; 37).
  • ImmunosuppressantsImmunosuppressants: Based on human studies, supplementation with probiotics has been shown to enhance various immune system parameters in healthy subjects (29; 44; 18; 19; 49), in HIV-positive subjects (47), and during vaccination (38; 37).
  • VaccinesVaccines: In human studies, supplementation with probiotics has been shown to enhance various immune system parameters in healthy subjects (29; 44; 18; 19; 49), in HIV-positive subjects (47), and during vaccination (38; 37).

    • Probiotics/Herb/Supplement Interactions:

  • Anti-inflammatory herbs and supplementsAnti-inflammatory herbs and supplements: Increases in serum IL-1-beta have been observed following LGG supplementation; however, no differences were seen in IL-6, TNF-alpha, MPO, IL-10, or IL-12 (33).
  • ImmunostimulantsImmunostimulants: In human studies, supplementation with probiotics has been shown to enhance various immune system parameters in healthy subjects (29; 44; 18; 19; 49), in HIV-positive subjects (47), and during vaccination (38; 37).
  • ImmunosuppressantsImmunosuppressants: In human studies, supplementation with probiotics has been shown to enhance various immune system parameters in healthy subjects (29; 44; 18; 19; 49), in HIV-positive subjects (47), and during vaccination (38; 37).

    • Probiotics/Food Interactions:

  • Insufficient available evidence.

    • Probiotics/Lab Interactions:

  • Immune panelImmune panel: In human studies, supplementation with probiotics has been shown to enhance various immune system parameters in healthy subjects (29; 44; 18; 19; 49), in HIV-positive subjects (47), and during vaccination (38; 37).